Biosergen AS
Biosergen AS develops variants of nystatin with improved properties.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Biosergen AS Information
Geographic Data
Address:
City: Trondheim
State: Sor-Trondelag
Zip:
Country: Norway
Financial Info
Stage:
grant
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Biosergen AS develops variants of nystatin with improved properties. Its pipeline products include S44HP, an antibiotic that is more potent than nystatin against several fungal pathogens; and nystatin analogues produced through manipulation of the nystatin biosynthetic genes.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2013 | Funding Round | 2 | - |
Rosetta Capital SINTEF Venture AS Rosetta Capital SINTEF Venture AS |
2/2016 | Grant | - | 2/2016 | Grant | - | 2/2013 | Funding Round | 2 | - |
Rosetta Capital SINTEF Venture AS Rosetta Capital SINTEF Venture AS |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
